Oncology Voice Network
Join to access to all OVN content. Join for Free
10 Tips for a Successful MSL Interview with Sue Watson
Sue Watson Oncology Medical Affairs MSL Interview Tips Janssen Pharmaceuticals Successful MSL Interview

10 Tips for a Successful MSL Interview with Sue Watson

  • May 5th 2020
  • 38 mins
  • E7

Share This Article

Summary

My guest today is Sue Watson. Sue is the Scientific Director, Oncology Medical Affairs, Janssen Pharmaceuticals, Johnson & Johnson. Our topic today is 10 Tips for a Successful MSL interview.

In this episode:

  • Who is Sue and what she’s doing
  • Sue’s advice as candidates start to prepare the interview
  • Tips for a successful MSL Interview
  • Bring interest and enthusiasm
  • Know the company
  • Know who is interviewing you
  • Know the role of an MSL
  • Prepare for your presentation
  • Anticipate the questions they will ask you
  • Prepare a 30-60-90 day plan
  • Prepare a list of questions for you to ask the interviewers
  • Dress for the interview
  • Send thank you email
  • Advice to aspiring MSLs trying to break into the role

Click for Source
Sue Watson, Oncology Medical Affairs, MSL Interview Tips, Janssen Pharmaceuticals, Successful MSL Interview

Related Topics

Explore the Ecosystem

Meet Our Innovation Partners

You May Also Like

Article
Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation
Partner Avatar Bridget Rasmusson

Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation

Oct 12th • 1 min • read
Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Apr 1st • 30 mins • read
Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Apr 29th • 8 mins • read
Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Apr 26th • 15 mins • read
Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Sep 27th • 1 min • read
Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Sep 26th • 17 mins • read

Explore OVN

Articles Expert-written insights
Browse Topics Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN